(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KRT19 mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression ISO RGD:733915 6480464 ethylene dichloride results in decreased expression of KRT19 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:733915 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KRT19 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of KRT19 mRNA CTD PMID:21983209 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of KRT19 mRNA CTD PMID:25380136 1-naphthyl isothiocyanate multiple interactions ISO RGD:733915 6480464 IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of KRT19 protein] more ... CTD PMID:24633426 , PMID:26921287 1-naphthyl isothiocyanate increases expression ISO RGD:733915 6480464 1-Naphthylisothiocyanate results in increased expression of KRT19 protein CTD PMID:21037076 more ... 17alpha-ethynylestradiol affects expression ISO RGD:733915 6480464 Ethinyl Estradiol affects the expression of KRT19 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of KRT19 mRNA CTD PMID:16174780 , PMID:17557909 17alpha-ethynylestradiol increases expression ISO RGD:733915 6480464 Ethinyl Estradiol results in increased expression of KRT19 mRNA CTD PMID:16174780 , PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:733915 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRT19 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:733914 6480464 3 more ... CTD PMID:11179685 more ... 17beta-estradiol increases expression ISO RGD:733914 6480464 Estradiol results in increased expression of KRT19 mRNA CTD PMID:11179685 more ... 17beta-estradiol increases expression ISO RGD:733915 6480464 Estradiol results in increased expression of KRT19 mRNA CTD PMID:15289156 , PMID:19484750 17beta-estradiol decreases expression ISO RGD:733915 6480464 Estradiol results in decreased expression of KRT19 mRNA CTD PMID:17640349 17beta-estradiol affects expression ISO RGD:733915 6480464 Estradiol affects the expression of KRT19 mRNA CTD PMID:15598610 17beta-estradiol affects expression ISO RGD:733914 6480464 Estradiol affects the expression of KRT19 mRNA CTD PMID:14699072 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733915 6480464 Dihydrotestosterone results in increased expression of KRT19 mRNA CTD PMID:17023530 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733914 6480464 Dihydrotestosterone results in increased expression of KRT19 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733914 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of KRT19 mRNA] CTD PMID:11179685 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KRT19 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733914 6480464 Tetrachlorodibenzodioxin results in decreased expression of KRT19 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733915 6480464 Tetrachlorodibenzodioxin results in decreased expression of KRT19 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of KRT19 mRNA CTD PMID:21602191 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733915 6480464 Tetrachlorodibenzodioxin results in increased expression of KRT19 mRNA CTD PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733915 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRT19 mRNA, WNT3A protein inhibits the reaction [[Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of KRT19 mRNA] CTD PMID:17942748 , PMID:21602191 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:733914 6480464 2 more ... CTD PMID:17547211 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of KRT19 mRNA, 2-Acetylaminofluorene results in increased expression of KRT19 protein CTD PMID:15133858 , PMID:17187413 2-acetamidofluorene multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of KRT19 protein CTD PMID:17661067 2-amino-14,16-dimethyloctadecan-3-ol increases expression ISO RGD:733914 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in increased expression of KRT19 protein CTD PMID:32044396 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of KRT19 mRNA CTD PMID:21061450 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3'-diindolylmethane multiple interactions ISO RGD:733914 6480464 3 more ... CTD PMID:11179685 , PMID:20160136 3,3'-diindolylmethane increases expression ISO RGD:733914 6480464 3, 3'-diindolylmethane results in increased expression of KRT19 mRNA CTD PMID:20160136 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression ISO RGD:733915 6480464 3 more ... CTD PMID:17585168 more ... 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:733915 6480464 GW 3965 inhibits the reaction [3 more ... CTD PMID:27052460 , PMID:30825315 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733914 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of KRT19 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of KRT19 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:733915 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of KRT19 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:733915 6480464 Fenretinide results in increased expression of KRT19 mRNA CTD PMID:28973697 5-azacytidine increases expression ISO RGD:733914 6480464 Azacitidine results in increased expression of KRT19 mRNA CTD PMID:20823114 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of KRT19 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:22248470 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 9-cis-retinoic acid increases expression ISO RGD:733914 6480464 Alitretinoin results in increased expression of KRT19 mRNA, Alitretinoin results in increased expression of KRT19 protein CTD PMID:11214822 more ... acetamide increases expression EXP 6480464 acetamide results in increased expression of KRT19 mRNA CTD PMID:31881176 afimoxifene decreases expression ISO RGD:733915 6480464 afimoxifene results in decreased expression of KRT19 mRNA CTD PMID:17640349 aflatoxin B1 decreases expression ISO RGD:733915 6480464 Aflatoxin B1 results in decreased expression of KRT19 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:733914 6480464 Aflatoxin B1 results in increased expression of KRT19 mRNA CTD PMID:21641981 , PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of KRT19 mRNA CTD PMID:23630614 more ... all-trans-4-oxoretinoic acid increases expression ISO RGD:733914 6480464 4-oxoretinoic acid results in increased expression of KRT19 mRNA, 4-oxoretinoic acid results in increased expression of KRT19 protein CTD PMID:15982314 , PMID:17034753 all-trans-4-oxoretinol increases expression ISO RGD:733914 6480464 4-oxoretinol results in increased expression of KRT19 mRNA CTD PMID:17034753 all-trans-retinoic acid increases expression ISO RGD:733914 6480464 Tretinoin metabolite results in increased expression of KRT19 mRNA more ... CTD PMID:11214822 more ... all-trans-retinoic acid multiple interactions ISO RGD:733915 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KRT19 mRNA, Tretinoin inhibits the reaction [RARA gene mutant form results in decreased expression of KRT19 mRNA] CTD PMID:10748128 , PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:733915 6480464 Tretinoin results in increased expression of KRT19 mRNA CTD PMID:10748128 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of KRT19 mRNA CTD PMID:21274875 , PMID:24977338 all-trans-retinoic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Tretinoin results in decreased expression of KRT19 mRNA] CTD PMID:21274875 all-trans-retinol increases expression ISO RGD:733914 6480464 Vitamin A results in increased expression of KRT19 mRNA CTD PMID:17034753 all-trans-retinol decreases expression EXP 6480464 Vitamin A deficiency results in decreased expression of KRT19 mRNA CTD PMID:12163651 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KRT19 mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of KRT19 protein CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of KRT19 mRNA CTD PMID:30779732 antimycin A decreases expression ISO RGD:733914 6480464 Antimycin A results in decreased expression of KRT19 mRNA CTD PMID:33512557 aristolochic acid A increases expression ISO RGD:733914 6480464 aristolochic acid I results in increased expression of KRT19 mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:733915 6480464 arsenite results in increased expression of KRT19 mRNA CTD PMID:18991936 arsenite(3-) increases expression ISO RGD:733914 6480464 arsenite results in increased expression of KRT19 mRNA, arsenite results in increased expression of KRT19 protein CTD PMID:22011395 arsenous acid decreases expression ISO RGD:733914 6480464 Arsenic Trioxide results in decreased expression of KRT19 mRNA, Arsenic Trioxide results in decreased expression of KRT19 protein CTD PMID:25419056 more ... arsenous acid decreases response to substance ISO RGD:733914 6480464 KRT19 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 benzo[a]pyrene affects expression ISO RGD:733914 6480464 Benzo(a)pyrene affects the expression of KRT19 mRNA CTD PMID:20106945 benzo[a]pyrene affects methylation ISO RGD:733914 6480464 Benzo(a)pyrene affects the methylation of KRT19 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:733914 6480464 Benzo(a)pyrene results in increased methylation of KRT19 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:733915 6480464 Benzo(a)pyrene results in decreased expression of KRT19 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:733914 6480464 Benzo(a)pyrene results in increased expression of KRT19 mRNA, Benzo(a)pyrene results in increased expression of KRT19 protein CTD PMID:17292933 more ... benzo[a]pyrene diol epoxide I affects expression ISO RGD:733914 6480464 7 more ... CTD PMID:20382639 beta-carotene increases expression ISO RGD:733914 6480464 beta Carotene results in increased expression of KRT19 mRNA CTD PMID:17034753 beta-hexachlorocyclohexane increases expression ISO RGD:733915 6480464 beta-hexachlorocyclohexane results in increased expression of KRT19 mRNA CTD PMID:17640349 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KRT19 mRNA CTD PMID:18164116 beta-naphthoflavone increases expression ISO RGD:733914 6480464 beta-Naphthoflavone results in increased expression of KRT19 mRNA CTD PMID:32151702 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:733914 6480464 Mustard Gas results in increased phosphorylation of KRT19 protein CTD PMID:19845377 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733914 6480464 Diethylhexyl Phthalate results in increased expression of KRT19 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:733914 6480464 bisphenol A affects the expression of KRT19 mRNA CTD PMID:19490990 , PMID:30903817 bisphenol A decreases expression ISO RGD:733914 6480464 bisphenol A analog results in decreased expression of KRT19 mRNA, bisphenol A results in decreased expression of KRT19 protein CTD PMID:32387340 , PMID:34186270 bisphenol A increases expression ISO RGD:733915 6480464 bisphenol A results in increased expression of KRT19 mRNA CTD PMID:30951980 more ... bisphenol A decreases expression ISO RGD:733915 6480464 bisphenol A results in decreased expression of KRT19 mRNA CTD PMID:29161229 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KRT19 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of KRT19 mRNA CTD PMID:26496021 Bisphenol B increases expression ISO RGD:733914 6480464 bisphenol B results in increased expression of KRT19 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733915 6480464 bisphenol F results in increased expression of KRT19 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:733915 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KRT19 mRNA CTD PMID:30951980 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of KRT19 protein CTD PMID:25933445 boron nitride decreases expression ISO RGD:733914 6480464 boron nitride results in decreased expression of KRT19 mRNA CTD PMID:30644070 butan-1-ol multiple interactions ISO RGD:733914 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT19 mRNA CTD PMID:29432896 butanal increases expression ISO RGD:733914 6480464 butyraldehyde results in increased expression of KRT19 mRNA CTD PMID:26079696 butane-2,3-dione decreases expression ISO RGD:733914 6480464 Diacetyl results in decreased expression of KRT19 protein CTD PMID:34031698 cadmium atom increases expression ISO RGD:733914 6480464 Cadmium results in increased expression of KRT19 mRNA CTD PMID:24376830 cadmium dichloride decreases expression ISO RGD:733914 6480464 Cadmium Chloride results in decreased expression of KRT19 mRNA CTD PMID:25596134 calcitriol increases expression ISO RGD:733914 6480464 Calcitriol results in increased expression of KRT19 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:733915 6480464 Nanotubes, Carbon analog results in decreased expression of KRT19 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:733915 6480464 Nanotubes more ... CTD PMID:25554681 chloroacetaldehyde increases expression ISO RGD:733914 6480464 chloroacetaldehyde results in increased expression of KRT19 mRNA CTD PMID:25596134 chloropicrin decreases expression ISO RGD:733914 6480464 chloropicrin results in decreased expression of KRT19 mRNA CTD PMID:28476498 cholesterol multiple interactions ISO RGD:733914 6480464 Cholesterol inhibits the reaction [arachidonyl dopamine results in increased expression of KRT19 mRNA] CTD PMID:33393692 choline multiple interactions ISO RGD:733915 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of KRT19 more ... CTD PMID:20938992 chromium(6+) affects expression ISO RGD:733915 6480464 chromium hexavalent ion affects the expression of KRT19 mRNA CTD PMID:28472532 cidofovir anhydrous increases expression ISO RGD:733914 6480464 Cidofovir results in increased expression of KRT19 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:733914 6480464 Cisplatin results in decreased expression of KRT19 mRNA CTD PMID:16061661 cisplatin multiple interactions ISO RGD:733914 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of KRT19 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:733914 6480464 Cisplatin results in increased expression of KRT19 mRNA CTD PMID:25596134 cobalt dichloride increases expression ISO RGD:733914 6480464 cobaltous chloride results in increased expression of KRT19 mRNA CTD PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of KRT19 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:733914 6480464 cobaltous chloride results in decreased expression of KRT19 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:733915 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT19 mRNA CTD PMID:15467011 copper atom decreases expression EXP 6480464 Copper results in decreased expression of KRT19 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:733915 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT19 mRNA CTD PMID:15467011 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of KRT19 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:733914 6480464 Copper Sulfate results in increased expression of KRT19 mRNA CTD PMID:19549813 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of KRT19 mRNA CTD PMID:18480146 crocidolite asbestos decreases expression ISO RGD:733914 6480464 Asbestos, Crocidolite results in decreased expression of KRT19 mRNA CTD PMID:28056339 cyclosporin A decreases expression ISO RGD:733914 6480464 Cyclosporine results in decreased expression of KRT19 mRNA CTD PMID:20106945 more ... cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of KRT19 mRNA CTD PMID:25596134 cyclosporin A increases expression ISO RGD:733914 6480464 Cyclosporine results in increased expression of KRT19 mRNA CTD PMID:25562108 cytarabine decreases expression ISO RGD:733914 6480464 Cytarabine results in decreased expression of KRT19 mRNA CTD PMID:21198554 daunorubicin increases expression EXP 6480464 Daunorubicin results in increased expression of KRT19 protein CTD PMID:2444108 dexamethasone multiple interactions ISO RGD:733914 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of KRT19 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:733914 6480464 Arsenic Trioxide results in decreased expression of KRT19 mRNA, Arsenic Trioxide results in decreased expression of KRT19 protein CTD PMID:25419056 more ... diarsenic trioxide decreases response to substance ISO RGD:733914 6480464 KRT19 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibutyl phthalate increases expression ISO RGD:733915 6480464 Dibutyl Phthalate results in increased expression of KRT19 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:733914 6480464 dicrotophos results in decreased expression of KRT19 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:733915 6480464 Diethylstilbestrol results in increased expression of KRT19 mRNA CTD PMID:15289156 , PMID:16636312 dioxygen increases expression ISO RGD:733915 6480464 Oxygen deficiency results in increased expression of KRT19 mRNA CTD PMID:20880076 dioxygen multiple interactions ISO RGD:733915 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT19 mRNA CTD PMID:30529165 diuron increases expression EXP 6480464 Diuron results in increased expression of KRT19 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733914 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:733914 6480464 Doxorubicin results in increased expression of KRT19 mRNA CTD PMID:28940058 more ... doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of KRT19 mRNA CTD PMID:32289291 elemental selenium increases expression ISO RGD:733914 6480464 Selenium results in increased expression of KRT19 mRNA CTD PMID:19244175 emodin decreases expression ISO RGD:733914 6480464 Emodin results in decreased expression of KRT19 mRNA CTD PMID:16045814 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of KRT19 mRNA CTD PMID:29391264 enzalutamide affects expression ISO RGD:733914 6480464 enzalutamide affects the expression of KRT19 mRNA CTD PMID:30940724 ethanol multiple interactions ISO RGD:733914 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT19 mRNA CTD PMID:29432896 etoposide increases expression ISO RGD:733914 6480464 Etoposide results in increased expression of KRT19 mRNA CTD PMID:29397400 folic acid multiple interactions ISO RGD:733915 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folpet increases expression ISO RGD:733915 6480464 folpet results in increased expression of KRT19 mRNA CTD PMID:31558096 furan increases expression EXP 6480464 furan results in increased expression of KRT19 mRNA CTD PMID:26194646 , PMID:27387713 genistein increases expression ISO RGD:733915 6480464 Genistein results in increased expression of KRT19 mRNA CTD PMID:15289156 genistein decreases expression EXP 6480464 Genistein results in decreased expression of KRT19 protein CTD PMID:22649256 genistein increases expression EXP 6480464 Genistein results in increased expression of KRT19 mRNA CTD PMID:22504913 genistein increases expression ISO RGD:733914 6480464 Genistein results in increased expression of KRT19 protein CTD PMID:20884965 genistein multiple interactions ISO RGD:733914 6480464 ESR1 promotes the reaction [Genistein results in increased expression of KRT19 protein], ESR2 promotes the reaction [Genistein results in increased expression of KRT19 protein] CTD PMID:20884965 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of KRT19 mRNA CTD PMID:33387578 glycidol increases expression ISO RGD:733915 6480464 glycidol results in increased expression of KRT19 mRNA CTD PMID:33187795 GW 3965 multiple interactions ISO RGD:733915 6480464 GW 3965 inhibits the reaction [3 more ... CTD PMID:27052460 hydrogen peroxide increases expression ISO RGD:733914 6480464 Hydrogen Peroxide results in increased expression of KRT19 mRNA CTD PMID:32949572 hydroquinone decreases expression ISO RGD:733914 6480464 hydroquinone results in decreased expression of KRT19 mRNA CTD PMID:31256213 ifosfamide increases expression ISO RGD:733914 6480464 Ifosfamide results in increased expression of KRT19 mRNA CTD PMID:25596134 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:733914 6480464 indeno(1 more ... CTD PMID:32251684 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of KRT19 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:733914 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of KRT19 mRNA CTD PMID:28628672 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 isotretinoin increases expression ISO RGD:733914 6480464 Isotretinoin results in increased expression of KRT19 mRNA, Isotretinoin results in increased expression of KRT19 protein CTD PMID:15982314 L-methionine multiple interactions ISO RGD:733915 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of KRT19 more ... CTD PMID:20938992 lithium chloride increases expression ISO RGD:733914 6480464 Lithium Chloride results in increased expression of KRT19 mRNA CTD PMID:23527032 metformin increases expression EXP 6480464 Metformin results in increased expression of KRT19 mRNA CTD PMID:25596134 methylmercury chloride decreases expression ISO RGD:733914 6480464 methylmercuric chloride results in decreased expression of KRT19 mRNA CTD PMID:23179753 more ... Monobutylphthalate increases expression ISO RGD:733915 6480464 monobutyl phthalate results in increased expression of KRT19 protein CTD PMID:20553848 monosodium L-glutamate increases expression ISO RGD:733915 6480464 Sodium Glutamate results in increased expression of KRT19 mRNA CTD PMID:20111022 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KRT19 mRNA more ... CTD PMID:18164116 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of KRT19 mRNA, Diethylnitrosamine results in increased expression of KRT19 protein CTD PMID:19638242 , PMID:20935162 N-nitrosodimethylamine increases expression ISO RGD:733914 6480464 Dimethylnitrosamine results in increased expression of KRT19 mRNA CTD PMID:17547211 naphthalene increases expression ISO RGD:733915 6480464 naphthalene results in increased expression of KRT19 protein CTD PMID:19438287 natamycin increases expression ISO RGD:733915 6480464 Natamycin results in increased expression of KRT19 mRNA CTD PMID:22863853 nickel atom decreases expression ISO RGD:733914 6480464 Nickel results in decreased expression of KRT19 mRNA CTD PMID:24768652 , PMID:25583101 nystatin increases expression ISO RGD:733915 6480464 Nystatin results in increased expression of KRT19 mRNA CTD PMID:22863853 ozone increases expression ISO RGD:733915 6480464 Ozone results in increased expression of KRT19 mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:733915 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KRT19 mRNA more ... CTD PMID:25658374 , PMID:34911549 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of KRT19 mRNA CTD PMID:18754875 panobinostat multiple interactions ISO RGD:733914 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT19 mRNA CTD PMID:27188386 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of KRT19 mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of KRT19 mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:733914 6480464 pentanal results in increased expression of KRT19 mRNA CTD PMID:26079696 perfluorooctanoic acid decreases expression ISO RGD:733914 6480464 perfluorooctanoic acid results in decreased expression of KRT19 protein CTD PMID:26879310 perfluorooctanoic acid increases expression ISO RGD:733915 6480464 perfluorooctanoic acid results in increased expression of KRT19 protein CTD PMID:36214631 phenobarbital multiple interactions ISO RGD:733915 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of KRT19 mRNA] CTD PMID:19482888 phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of KRT19 protein CTD PMID:20935162 phenobarbital increases expression ISO RGD:733915 6480464 Phenobarbital results in increased expression of KRT19 mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO RGD:733914 6480464 Phenylmercuric Acetate results in increased expression of KRT19 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733914 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT19 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of KRT19 mRNA CTD PMID:15215175 phosgene affects expression ISO RGD:733915 6480464 Phosgene affects the expression of KRT19 mRNA CTD PMID:16300373 picene decreases expression ISO RGD:733914 6480464 picene results in decreased expression of KRT19 mRNA CTD PMID:32251684 picoxystrobin decreases expression ISO RGD:733914 6480464 picoxystrobin results in decreased expression of KRT19 mRNA CTD PMID:33512557 pirinixic acid decreases expression ISO RGD:733915 6480464 pirinixic acid results in decreased expression of KRT19 mRNA CTD PMID:17426115 potassium chromate increases expression ISO RGD:733914 6480464 potassium chromate(VI) results in increased expression of KRT19 mRNA CTD PMID:22714537 propanal increases expression ISO RGD:733914 6480464 propionaldehyde results in increased expression of KRT19 mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:733914 6480464 Quercetin results in increased expression of KRT19 mRNA, Quercetin results in increased expression of KRT19 protein CTD PMID:14750173 , PMID:21632981 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of KRT19 mRNA CTD PMID:25905778 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of KRT19 mRNA CTD PMID:25905778 SB 431542 multiple interactions ISO RGD:733914 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SB 431542 increases expression ISO RGD:733914 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of KRT19 protein CTD PMID:25670856 selenium atom increases expression ISO RGD:733914 6480464 Selenium results in increased expression of KRT19 mRNA CTD PMID:19244175 senecionine decreases expression ISO RGD:733915 6480464 senecionine results in decreased expression of KRT19 protein CTD PMID:35357534 serpentine asbestos decreases expression ISO RGD:733914 6480464 Asbestos, Serpentine results in decreased expression of KRT19 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:733914 6480464 Silicon Dioxide analog results in increased expression of KRT19 mRNA CTD PMID:25895662 sodium arsenite affects expression ISO RGD:733915 6480464 sodium arsenite affects the expression of KRT19 mRNA CTD PMID:16507464 sodium arsenite increases expression ISO RGD:733915 6480464 sodium arsenite results in increased expression of KRT19 mRNA, sodium arsenite results in increased expression of KRT19 protein CTD PMID:17350061 , PMID:29044176 sodium arsenite decreases expression ISO RGD:733914 6480464 sodium arsenite results in decreased expression of KRT19 mRNA CTD PMID:12016162 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of KRT19 mRNA CTD PMID:25905778 sulindac sulfide decreases expression ISO RGD:733914 6480464 sulindac sulfide results in decreased expression of KRT19 mRNA CTD PMID:12734198 sunitinib decreases expression ISO RGD:733914 6480464 Sunitinib results in decreased expression of KRT19 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:733915 6480464 Tamoxifen affects the expression of KRT19 mRNA CTD PMID:17555576 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of KRT19 mRNA CTD PMID:26496021 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of KRT19 protein, schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KRT19 mRNA] CTD PMID:17661067 , PMID:31150632 tetrachloromethane multiple interactions ISO RGD:733915 6480464 GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of KRT19 mRNA] CTD PMID:32996673 tetrachloromethane increases expression ISO RGD:733915 6480464 Carbon Tetrachloride results in increased expression of KRT19 mRNA CTD PMID:32996673 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of KRT19 mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KRT19 mRNA CTD PMID:16770575 thapsigargin decreases expression ISO RGD:733914 6480464 Thapsigargin results in decreased expression of KRT19 mRNA CTD PMID:29453283 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of KRT19 mRNA CTD PMID:28943392 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of KRT19 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:733915 6480464 titanium dioxide results in increased expression of KRT19 mRNA CTD PMID:27760801 titanium dioxide decreases expression ISO RGD:733915 6480464 titanium dioxide results in decreased expression of KRT19 mRNA CTD PMID:23557971 toluene 2,4-diisocyanate multiple interactions ISO RGD:733914 6480464 [Toluene 2, 4-Diisocyanate binds to ALB protein] which results in increased expression of KRT19 mRNA CTD PMID:15478392 topotecan affects response to substance ISO RGD:733914 6480464 KRT19 protein affects the susceptibility to Topotecan CTD PMID:16217747 tranexamic acid multiple interactions ISO RGD:733915 6480464 Tranexamic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of KRT19 protein] CTD PMID:24633426 triadimefon decreases expression ISO RGD:733914 6480464 triadimefon results in decreased expression of KRT19 mRNA CTD PMID:26705709 tributylstannane increases expression ISO RGD:733915 6480464 tributyltin results in increased expression of KRT19 mRNA CTD PMID:31939706 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of KRT19 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:733914 6480464 trichostatin A results in increased expression of KRT19 mRNA CTD PMID:24935251 , PMID:26705709 triclosan increases expression ISO RGD:733914 6480464 Triclosan results in increased expression of KRT19 mRNA CTD PMID:30510588 tris(2-butoxyethyl) phosphate affects expression ISO RGD:733914 6480464 tris(2-butoxyethyl) phosphate affects the expression of KRT19 mRNA CTD PMID:29024780 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Tretinoin results in decreased expression of KRT19 mRNA] CTD PMID:21274875 valproic acid increases methylation ISO RGD:733914 6480464 Valproic Acid results in increased methylation of KRT19 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:733914 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT19 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733914 6480464 Valproic Acid results in increased expression of KRT19 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:733914 6480464 Valproic Acid affects the expression of KRT19 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of KRT19 mRNA CTD PMID:19015723 zinc atom increases expression ISO RGD:733915 6480464 Zinc deficiency results in increased expression of KRT19 mRNA CTD PMID:20857495 zinc(0) increases expression ISO RGD:733915 6480464 Zinc deficiency results in increased expression of KRT19 mRNA CTD PMID:20857495